Deployment and assessment of a deep learning model for real-time detection of anal precancer with high frame rate high-resolution microendoscopy.

Journal: Scientific reports
PMID:

Abstract

Anal cancer incidence is significantly higher in people living with HIV as HIV increases the oncogenic potential of human papillomavirus. The incidence of anal cancer in the United States has recently increased, with diagnosis and treatment hampered by high loss-to-follow-up rates. Novel methods for the automated, real-time diagnosis of AIN 2+ could enable "see and treat" strategies, reducing loss-to-follow-up rates. A previous retrospective study demonstrated that the accuracy of a high-resolution microendoscope (HRME) coupled with a deep learning model was comparable to expert clinical impression for diagnosis of AIN 2+ (sensitivity 0.92 [P = 0.68] and specificity 0.60 [P = 0.48]). However, motion artifacts and noise led to many images failing quality control (17%). Here, we present a high frame rate HRME (HF-HRME) with improved image quality, deployed in the clinic alongside a deep learning model and evaluated prospectively for detection of AIN 2+ in real-time. The HF-HRME reduced the fraction of images failing quality control to 4.6% by employing a high frame rate camera that enhances contrast and limits motion artifacts. The HF-HRME outperformed the previous HRME (P < 0.001) and clinical impression (P < 0.0001) in the detection of histopathologically confirmed AIN 2+ with a sensitivity of 0.91 and specificity of 0.87.

Authors

  • David Brenes
    Department of Bioengineering, Rice University, MS-142 6100 Main St., Houston, TX, 77005, USA. dbrenes@uw.edu.
  • Alex Kortum
    Department of Bioengineering, Rice University, MS-142 6100 Main St., Houston, TX, 77005, USA.
  • Jackson Coole
    Department of Bioengineering, Rice University, MS-142 6100 Main St., Houston, TX, 77005, USA.
  • Jennifer Carns
    Department of Bioengineering, Rice University, Houston, TX 77005, USA.
  • Richard Schwarz
    Department of Bioengineering, Rice University, MS-142 6100 Main St., Houston, TX, 77005, USA.
  • Imran Vohra
    Biotex, 114 Holmes Rd., Houston, TX, 77045, USA.
  • Rebecca Richards-Kortum
    Department of Bioengineering, Rice University, Houston, TX, USA.
  • Yuxin Liu
    School of Biomedical Engineering (Suzhou), University of Science and Technology of China, Division of Life Sciences and Medicine, Hefei, 230026, Anhui, China.
  • Zhenjian Cai
    Clinical Pathology Laboratories, 9200 Wall Street, Austin, TX, 78754, USA.
  • Keith Sigel
    Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, New York, NY, 10029, USA.
  • Sharmila Anandasabapathy
    Department of Gastroenterology, The Icahn School of Medicine at Mount Sinai, New York, New York.
  • Michael Gaisa
    Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, New York, NY, 10029, USA.
  • Elizabeth Chiao
    Department of Epidemiology, Division of Cancer Prevention, University of Texas - MD Anderson Cancer Center, 1155 Pressler St., Unit 1340, Houston, TX, 77030, USA. EYChiao@mdanderson.org.